2,4-Patchouladiene

CAS:
50430-14-3
Family:
sesquiterpene hydrocarbon
Also:
2,4-Patchouladiene, 4,10,11,11-tetramethyltricyclo[5.3.1.0(1,5)]undeca-2,4-diene

Found heavily in (1 oils total)

Recorded sensory reference values
  • Affect valence: 0.25
  • Affect arousal: -0.25

Reference values depend on measurement conditions and do not describe an effective dose or the perception of a custom blend.

2,4-Patchouladiene is a trace sesquiterpene hydrocarbon most useful in AromaForge as a composition and chemotaxonomic marker rather than a well-studied isolated bioactive. Live sources support its identity, structure, and occurrence in Cyperus and other essential-oil profiles, including the local Bengali nagarmotha record. Direct mechanism, human-use, and constituent-specific safety literature appear sparse in this research pass, so archive copy should present 2,4-patchouladiene as a niche patchouli-skeleton aroma constituent with clear evidence gaps rather than inferred wellness activity.

Chemical identity and composition

PubChem resolves 2,4-patchouladiene to CID 74819450 with formula C15H22 and InChIKey DPHLFUXQEZYZAP-UHFFFAOYSA-N. The local Bengali nagarmotha profile lists it at 1.04%, consistent with literature that places it among minor sesquiterpenes in Cyperus-related oils. The hydrogen count indicates a relatively unsaturated sesquiterpene hydrocarbon compared with more common C15H24 sesquiterpenes.

Aroma and practical use

woodyearthypatchouli-like
  • Use the recorded woody, earthy, patchouli-like descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
  • Read the route, preparation and experimental context before using a study finding to choose an oil.

Reported benefits and effects

Findings retain their study context. An animal or laboratory result describes that experiment.

A 1997 Phytochemistry paper on Cyperus alopecuroides reported 2,4-patchouladiene among the sesquiterpenes identified in hydrodistillation products by spectroscopic methods and chemical conversions.

This is the most direct source located for the compound as an individually identified natural-product constituent.

composition studyRoute not recorded

This reference does not establish a therapeutic result or a safe use level for a custom oil blend.

A 2021 Frontiers formula-composition paper listed 2,4-patchouladiene at 1.01% in a volatile-oil profile, showing that the compound continues to appear in modern GC-MS essential-oil datasets as a minor component rather than a dominant active.

This supports current analytical relevance without implying constituent-specific efficacy.

composition studyRoute not recorded

This reference does not establish a therapeutic result or a safe use level for a custom oil blend.

Use concerns and concentration limits

Sensitization concernNot flagged

Not flagged in the current model. This is not proof of absence or unrestricted safety.

Phototoxicity concernNot flagged

Not flagged in the current model. This is not proof of absence or unrestricted safety.

Oxidation concernNot flagged

Not flagged in the current model. This is not proof of absence or unrestricted safety.

Penetration enhancementNot flagged

Not flagged in the current model. This is not proof of absence or unrestricted safety.

Recorded dermal reference25%

A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.

unverified reference · No source provenance attached
No constituent-specific RIFM, IFRA, EFSA, or clinical safety review for isolated 2,4-patchouladiene was verified in this pass.
evidence gapRoute not recorded

This reference does not establish a therapeutic result or a safe use level for a custom oil blend.

No direct public citation is attached to this entry.

Because the located literature is mainly compositional, safety assumptions should not be extrapolated from other patchouli-related sesquiterpenes.
evidence synthesisRoute not recorded

This reference does not establish a therapeutic result or a safe use level for a custom oil blend.

No direct public citation is attached to this entry.

Constituents it may interact with

No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.

What this report cannot establish

  • A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
  • The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
  • An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
  • A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
  • Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (5)
  • No isolated human or animal pharmacology study specific to 2,4-patchouladiene was verified in this pass.
  • Constituent-specific odor descriptions from primary fragrance references were sparse, so the aroma descriptors here are conservative and structure-informed.
  • A standalone constituent-specific safety assessment was not located.
  • The numeric dermal reference lacks source provenance; a verified flag alone is insufficient.
  • Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.
All public references (4)